Jiang Yu-Li, Yu Dong-Dong, Xu Yang, Zhang Ming-Hua, Peng Fu-Sheng, Li Peng
Department of Urology, Hu Zhou Central Hospital, Huzhou, China.
Front Surg. 2023 Mar 15;10:1138974. doi: 10.3389/fsurg.2023.1138974. eCollection 2023.
To compare the perioperative outcomes of robotic partial nephrectomy (RPN) vs. laparoscopic partial nephrectomy (LPN) for complex renal tumors with a RENAL nephrometry score ≥7.
We searched PubMed, EMBASE and the Cochrane Central Register for studies from 2000 to 2020 to evaluate the perioperative outcomes of RPN and LPN in patients with a RENAL nephrometry score ≥7. We used RevMan 5.2 to pool the data.
Seven studies were acquired in our study. No significant differences were found in the estimated blood loss (WMD: 34.49; 95% CI: -75.16-144.14; = 0.54), hospital stay (WMD: -0.59; 95% CI: -1.24-0.06; = 0.07), positive surgical margin (OR: 0.85; 95% CI: 0.65-1.11; = 0.23), major postoperative complications (OR: 0.90; 95% CI: 0.52-1.54; = 0.69) and transfusion (OR: 0.72; 95% CI: 0.48-1.08; = 0.11) between the groups. RPN showed better outcomes in the operating time (WMD: -22.45; 95% CI: -35.06 to -9.85; = 0.0005), postoperative renal function (WMD: 3.32; 95% CI: 0.73-5.91; = 0.01), warm ischemia time (WMD: -6.96; 95% CI: -7.30--6.62; < 0.0001), conversion rate to radical nephrectomy (OR: 0.34; 95% CI: 0.17 to 0.66; = 0.002) and intraoperative complications (OR: 0.52; 95% CI: 0.28-0.97; = 0.04).
RPN is a safe and effective alternative to LPNs for or the treatment of complex renal tumors with a RENAL nephrometry score ≥7 with a shorter warm ischemic time and better postoperative renal function.
比较机器人辅助肾部分切除术(RPN)与腹腔镜肾部分切除术(LPN)治疗RENAL肾计量评分≥7的复杂肾肿瘤的围手术期结局。
我们检索了PubMed、EMBASE和Cochrane中央对照试验注册库,以获取2000年至2020年期间评估RENAL肾计量评分≥7的患者行RPN和LPN的围手术期结局的研究。我们使用RevMan 5.2对数据进行汇总。
我们的研究纳入了7项研究。两组在估计失血量(加权均数差:34.49;95%可信区间:-75.16至144.14;P = 0.54)、住院时间(加权均数差:-0.59;95%可信区间:-1.24至0.06;P = 0.07)、手术切缘阳性率(比值比:0.85;95%可信区间:0.65至1.11;P = 0.23)、术后主要并发症(比值比:0.90;95%可信区间:0.52至1.54;P = 0.69)和输血率(比值比:0.72;95%可信区间:0.48至1.08;P = 0.11)方面未发现显著差异。RPN在手术时间(加权均数差:-22.45;95%可信区间:-35.06至-9.85;P = 0.0005)、术后肾功能(加权均数差:3.32;95%可信区间:0.73至5.91;P = 0.01)、热缺血时间(加权均数差:-6.96;95%可信区间:-7.30至-6.62;P < (此处原文有误,应为P < 0.0001))、根治性肾切除术转化率(比值比:0.34;95%可信区间:0.17至0.66;P = 0.002)和术中并发症(比值比:0.52;95%可信区间:0.28至0.97;P = 0.04)方面显示出更好的结局。
对于治疗RENAL肾计量评分≥7的复杂肾肿瘤,RPN是LPN的一种安全有效的替代方法,热缺血时间更短且术后肾功能更好。